Reckitt Benckiser picks up BMS' OTC line in Latin America; Bangladesh-based Beximco exports to Europe;

> U.K.-based Reckitt Benckiser, the maker of Nurofen painkillers, will pay Bristol-Myers Squibb ($BMY) $482 million to license a portfolio of Latin American over-the-counter healthcare products as it expands its presence in emerging markets. Story

> Europeans keep pressure on drugmakers to not provide products that can be used in executions in the U.S. Story

> The Bangladesh-based API and drugmaker Beximco Pharmaceuticals is now exporting products to Europe. Item

> Schott Kaisha has invested $26.8 million in a new plant in Jambusar, Gujarat, India, to do pharmaceutical packaging. Item

> Sweden's CDMO Recipharm has been hired by PledPharma to produce the clinical trial material for an FDA-approved Phase IIb study. Release

And Finally... A federal judge closed Titan Medical Enterprises in Santa Fe Springs, CA, after the FDA complained that the drug and dietary supplement maker was not following sound manufacturing processes and had ignored its orders to quit making what it claimed were misbranded drugs. Release